Suggested Citation: "3 Opportunities for Real-World Data." National Academies of Sciences, Engineering, and Medicine. 2017. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings ...
MEDDDICAL has launched a real-world evidence analytics and advisory service, offering structured guidance to pharmaceutical and MedTech companies at a time when real-world evidence requirements from ...
Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...
Ben Urick, PharmD, PhD, examines GLP-1 coverage gaps and real-world evidence challenges shaping payer decisions and obesity treatment access. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...
Real-world evidence helps pharmaceutical companies and payers communicate more effectively. In this Q&A, Cate Lockhart, PharmD, PhD, chief science officer of the Academy of Managed Care Pharmacy (AMCP ...
Drug safety during pregnancy is an area of continued importance as substantial uncertainty persists regarding the safety of many medications, and the use of ...
Healthcare systems worldwide are facing unprecedented pressure, from the rise in chronic diseases and aging populations to fragmented healthcare and over-stretched resources. The result? Delayed, ...
Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.
It is easy to overlook the fact that over 90% of medical treatments are not backed by strong evidence. People can find it frustrating – even infuriating – when a review concludes that the evidence for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results